Oncolytic Adenovirus Harboring Interleukin-24 Improves Chemotherapy for Advanced Prostate Cancer.

Mao, Li-Jun; Ding, Meng; Xu, Kai; Pan, Jun; Yu, Haiyuan; Yang, Chunhua

Mao, Li-Jun; Ding, Meng; Xu, Kai; Pan, Jun; Yu, Haiyuan; Yang, Chunhua.

Afiliação

Mao LJ; Department of Urinary Surgery, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
Ding M; Department of Urinary Surgery, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
Xu K; Department of Urinary Surgery, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
Pan J; Department of Urinary Surgery, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
Yu H; Department of Urinary Surgery, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
Yang C; Department of Urinary Surgery, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.

J Cancer ; 9(23): 4391-4397, 2018.

Article em En | MEDLINE | ID: mdl-30519344

Palavras-chave

IL-24; Oncolytic adenovirus; docetaxel; prostate cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google